The DOI matches its Crossref record; 914 of the 914 references it cites were found in a registry or an index.
Human prostate cancer risk factors
Open accessAbstract
Prostate cancer has the highest prevalence of any nonskin cancer in the human body, with similar likelihood of neoplastic foci found within the prostates of men around the world regardless of diet, occupation, lifestyle, or other factors. Essentially all men with circulating androgens will develop microscopic prostate cancer if they live long enough. This review is a contemporary and comprehensive, literature-based analysis of the putative risk factors for human prostate cancer, and the results were presented at a multidisciplinary consensus conference held in Crystal City, Virginia, in the fall of 2002. The objectives were to evaluate known environmental factors and mechanisms of prostatic carcinogenesis and to identify existing data gaps and future research needs. The review is divided into four sections, including 1) epidemiology (endogenous factors [family history, hormones, race, aging and oxidative stress] and exogenous factors [diet, environmental agents, occupation and other factors, including lifestyle factors]); 2) animal and cell culture models for prediction of human risk (rodent models, transgenic models, mouse reconstitution models, severe combined immunodeficiency syndrome mouse models, canine models, xenograft models, and cell culture models); 3) biomarkers in prostate cancer, most of which have been tested only as predictive factors for patient outcome after treatment rather than as risk factors; and 4) genotoxic and nongenotoxic mechanisms of carcinogenesis. The authors conclude that most of the data regarding risk relies, of necessity, on epidemiologic studies, but animal and cell culture models offer promise in confirming some important findings. The current understanding of biomarkers of disease and risk factors is limited. An understanding of the risk factors for prostate cancer has practical importance for public health research and policy, genetic and nutritional education and chemoprevention, and prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 914
Family History and Prostate Cancer Risk
Lesko, S. M., Rosenberg, L. A., & Shapiro, S. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008876 · Cited by 147
Epidemiology of prostate cancer with special reference to the role of diet.
Hirayama, T. (1979) · PubMed · Cited by 146
The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3/beta 1.
Dedhar, S., Jewell, K., Rojiani, M. V., & Gray, V. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37047-4 · Cited by 146
Epidemiologic evidence regarding predisposing factors to prostate cancer
Carter, B. S., Carter, H. B., & Isaacs, J. T. (1990) · The Prostate · doi:10.1002/pros.2990160302 · Cited by 145
Studies of Genetic Factors in Prostate Cancer in a Twin Population
Grönberg, H., Damber, L., & Damber, J. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32452-7 · Cited by 145
Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada
Rohan, T. E., Howe, G. R., Burch, J. D., & Jain, M. G. (1995) · Cancer Causes & Control · doi:10.1007/bf00052775 · Cited by 144
Daviglus, M. L., Dyer, A. R., Persky, V., Chávez, N., Drum, M. L., Goldberg, J., Liu, K., Morris, D. K., Shekelle, R. B., & Stamler, J. (1996) · Epidemiology · doi:10.1097/00001648-199609000-00004 · Cited by 144
ErbB kinases and NDF signaling in human prostate cancer cells
Grasso, A. W., Wen, D., Miller, C. M., Rhim, J. S., Pretlow, T. G., & Kung, H.-J. (1997) · Oncogene · doi:10.1038/sj.onc.1201447 · Cited by 144
Ross, S., Spencer, S. D., Holcomb, I. N., Tan, C., Hongo, J.-A., Devaux, B., Rangell, L. K., Keller, G. A., Schow, P. W., Steeves, R. M., et al. (2002) · PubMed · Cited by 144
Harris, S. E., Harris, M. A., Mahy, P., Feng, J. Q., Mundy, G. R., & Wozney, J. M. (1994) · The Prostate · doi:10.1002/pros.2990240406 · Cited by 144
Hammond, G. L. (1978) · Journal of Endocrinology · doi:10.1677/joe.0.0780007 · Cited by 143
Chung, Y. M., Bae, Y. S., & Lee, S. Y. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01301-1 · Cited by 143
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens
Maru, N., Ohori, M., Kattan, M. W., Scardino, P. T., & Wheeler, T. M. (2001) · Human Pathology · doi:10.1053/hupa.2001.26456 · Cited by 143
Leptin Influences Cellular Differentiation And Progression In Prostrate Cancer
Sağlam, K., Aydur, E., Yılmaz, M. İ., et al. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000055903.18400.25 · Cited by 142
dl ‐α‐tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells
Sigounas, G., Anagnostou, A. A., & Steiner, M. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514549 · Cited by 142
Lichtinghagen, R., Musholt, P. B., Lein, M., Römer, A., Rudolph, B. D., Kristiansen, G., Hauptmann, S., Schnorr, D., Loening, S. A., & Jung, K. (2002) · European Urology · doi:10.1016/s0302-2838(02)00324-x · Cited by 141
Tamimi, Y., van der Poel, H. G., Denyn, M. M., Umbas, R., Karthaus, H. F. M., Debruyne, F. M. J., & Schalken, J. A. (1993) · PubMed · Cited by 141
Topography of neovascularity in human prostate carcinoma
Siegal, J. A., Yu, E., & Brawer, M. K. (1995) · Cancer · doi:10.1002/1097-0142(19950515)75:10<2545::aid-cncr2820751022>3.0.co;2-x · Cited by 140
Developmental estrogenization and prostatic neoplasia
Santti, R., Mäkelä, S., Pylkkänen, L. H., Newbold, R. R., & McLachlan, J. A. (1994) · The Prostate · doi:10.1002/pros.2990240204 · Cited by 140
Sero-epidemiologal association between human-papillomavirus infection and risk of prostate cancer
Dillner, J., Knekt, P., Boman, J., Lehtinen, M., af Geijersstam, V., Sapp, M. J., Schiller, J. T., Maatela, J., & Aromaa, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980209)75:4<564::aid-ijc12>3.0.co;2-9 · Cited by 140
Djakiew, D., Delsite, R., Pflug, B. R., Wrathall, J. R., Lynch, J. H., & Onoda, M. (1991) · PubMed · Cited by 140
Self-citationCan nutrition explain the pattern of international epidemiology of hormone-dependent cancers?
Berg, J. W. (1975) · PubMed · Cited by 140
Milon, L., Rousseau-Merck, M.-F., Munier, A., Erent, M., Lascu, I., Capeau, J., & Lacombe, M. (1997) · Human Genetics · doi:10.1007/s004390050405 · Cited by 139
Theodorescu, D., Broder, S. R., Boyd, J. C., Mills, S. E., & Frierson, H. F. (1997) · The Journal of Urology · doi:10.1097/00005392-199707000-00040 · Cited by 139
Doll, J. A., Reiher, F., Crawford, S. E., Pins, M. R., Campbell, S. C., & Bouck, N. (2001) · The Prostate · doi:10.1002/pros.10025 · Cited by 138
Guo, Y., Jacobs, S. C., & Kyprianou, N. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<573::aid-ijc11>3.0.co;2-d · Cited by 138
Bentley, H., Hamdy, F. C., Hart, K., Seid, J. M., Williams, J. L., Johnstone, D., & Russell, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.427 · Cited by 138
Alcohol and other beverage use and prostate cancer risk among Canadian men
Jain, M. G., Hislop, G. T., Howe, G. R., Burch, J. D., & Ghadirian, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981209)78:6<707::aid-ijc7>3.0.co;2-2 · Cited by 137
Kuefer, R., Varambally, S., Zhou, M., Lucas, P. C., Loeffler, M., Wolter, H., Mattfeldt, T., Hautmann, R. E., Gschwend, J. E., Barrette, T. R., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64244-7 · Cited by 137
McDonnel, T. J., Navone, N. M., Troncoso, P., Pisters, L. L., Conti, C. J., von Eschenbach, A. C., Brisbay, S. M., & Logothetis, C. J. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65204-2 · Cited by 137
Insulin-like growth factors and prostate cancer
Djavan, B., Waldert, M., Seitz, C., & Marberger, M. (2001) · World Journal of Urology · doi:10.1007/s003450100220 · Cited by 137
Ho, P. J., & Baxter, R. C. (1997) · PubMed · Cited by 137
SIEMIATYCKI, J., KREWSKI, D., FRANCO, E., & KAISERMAN, M. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.3.504 · Cited by 137
Haudenschild, D. R., Moseley, T. A., Rose, L., & Reddi, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109372200 · Cited by 136
Insulin-like growth factor-I and prostate cancer: a meta-analysis
Shi, R., Berkel, H. J., & Yu, H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1961 · Cited by 136
Hamdy, F. C., Fadlon, E., Cottam, D. W., Lawry, J., Thurrell, W., Silcocks, P., Anderson, J., Williams, J., & Rees, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.30 · Cited by 136
Molecular Profiling of Angiogenesis Markers
Shih, S., Robinson, G. S., Perruzzi, C. A., Calvo, A., Desai, K. V., Green, J. E., Ali, I. U., Smith, L. E. H., & Senger, D. R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64154-5 · Cited by 135
Buchanan, G., Yang, M., Harris, J. M., Nahm, H. S., Han, G., Moore, N. L. T., Bentel, J. M., Matusik, R. J., Horsfall, D. J., Marshall, V. R., et al. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0581 · Cited by 135
Androgen Receptor CAG Repeats and Prostate Cancer
Nelson, K. A., & Witte, J. S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.10.883 · Cited by 134
Design of the Prostate Cancer Prevention Trial (PCPT)
Feigl, P., Blumenstein, B. A., Thompson, I. M., Crowley, J. J., Wolf, M., Kramer, B. S., Coltman, C. A., Brawley, O. W., & Ford, L. G. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00xxx-m · Cited by 132
Physical activity and its relation to cancer risk: a prospective study of college alumni
Lee, I.-M. M., & Paffenbarger, R. S. (1994) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199407000-00004 · Cited by 132
Farming and Prostate Cancer Mortality
MORRISON, H. I., Savitz, D. A., Semenciw, R. M., et al. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116674 · Cited by 131
Self-citationWebber, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1225 · Cited by 131
An uncertain role for p53 gene alterations in human prostate cancers.
Brooks, J. D., Bova, G. S., Ewing, C. M., Piantadosi, S., Carter, B. S., Robinson, J. C., Epstein, J. I., & Isaacs, W. B. (1996) · PubMed · Cited by 130
Sherwood, E. R., Berg, L. A., Mitchell, N. J., McNeal, J. E., Kozlowski, J. M., & Lee, C. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39903-2 · Cited by 128
Dalu, A., Haskell, J. F., Coward, L. U., & Lamartiniere, C. A. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980915)37:1<36::aid-pros6>3.0.co;2-6 · Cited by 128
Expression of transforming growth factor-beta 1 in prostate cancer
Steiner, M. S., Zhou, Z. Z., Tonb, D. C., & Barrack, E. R. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956947 · Cited by 128
Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical Prostatectomy
Bettencourt, M., Bauer, J. J., Sesterhenn, I. A., Mostofi, F. K., McLeod, D. G., & Moul, J. W. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65703-3 · Cited by 128
Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study.
Hietanen, E. K., Bartsch, H. S., Béréziat, J., Camus, A. ‐., McClinton, S., Eremin, O., Davidson, L., & Boyle, P. (1994) · PubMed · Cited by 127
Prostate carcinoma incidence and patient mortality
Brawley, O. W. (1997) · Cancer · Cited by 127
Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
Joos, S., Bergerheim, U. S. R., Pan, Y., Matsuyama, H., Bentz, M., du Manoir, S., & Lichter, P. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140405 · Cited by 127
Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas
Brooks, J. D., Bova, G. S., & Isaacs, W. B. (1995) · The Prostate · doi:10.1002/pros.2990260108 · Cited by 127
Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty, K. M., Blomme, E. A. G., Koh, A. J., et al. (1999) · PubMed · Cited by 127
Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.
Tran, C. P., Lin, C. H., Yamashiro, J. M., & Reiter, R. E. (2002) · PubMed · Cited by 127
Chan, J. M., Pietinen, P., Virtanen, M. J., Malila, N. K., Tangrea, J. A., Albanes, D., & Virtamo, J. (2000) · Cancer Causes & Control · doi:10.1023/a:1008947201132 · Cited by 126
Effect of androgen on the transcription of rat prostatic binding protein genes
Pagé, M., & Parker, M. G. (1982) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(82)90099-5 · Cited by 126
Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta, S., Ahmad, N., Marengo, S. R., MacLennan, G. T., Greenberg, N. M., & Mukhtar, H. (2000) · PubMed · Cited by 126
Tomatoes, Lycopene, and Prostate Cancer
Giovannucci, E. L., & Clinton, S. K. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-218-44277 · Cited by 126
Gupta, S., Ahmad, N., Mohan, R. R., Husain, M. M., & Mukhtar, H. (1999) · PubMed · Cited by 125
METHYLATION OF THE E-CADHERIN GENE PROMOTER CORRELATES WITH PROGRESSION OF PROSTATE CANCER
Li, L., ZHAO, H., Nakajima, K., Oh, B. R., Ribeiro‐Filho, L. A., Carroll, P. R., & Dahiya, R. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66047-8 · Cited by 125
Wang, Y., & Sun, Y. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023333863 · Cited by 125
Prostate Cancer Risk in California Farm Workers
Mills, P. K., & Yang, R. C. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000058339.05741.0c · Cited by 125
Family history and prostate cancer risk in a population-based cohort of Iowa men.
Cerhan, J. R., Parker, A. S., Putnam, S. D., Chiu, B. C. ‐., Lynch, C. F., Cohen, M. B., Torner, J. C., & Cantor, K. P. (1999) · PubMed · Cited by 124
Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats
Iszard, M. (1995) · Toxicology · doi:10.1016/0300-483x(95)03118-y · Cited by 124
Cigarette smoking and risk of prostate cancer in middle-aged men.
Plaskon, L. A., Penson, D. F., Vaughan, T. L., & Stanford, J. L. (2003) · PubMed · Cited by 124
Marchand, L. L., Hankin, J. H., Kolonel, L. N., & Wilkens, L. R. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115865 · Cited by 124
Han, G., Foster, B. A., Mistry, S. G., Buchanan, G., Harris, J. M., Tilley, W. D., & Greenberg, N. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008207200 · Cited by 123
Shi, Y., Brands, F., CHATTERJEE, S., Feng, A., Groshen, S. G., Schewe, J., Lieskovsky, G., & Côté, R. J. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65822-3 · Cited by 122
The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention
Nelson, W. G., Marzo, A. M. D., & DeWeese, T. L. (2001) · Urology · doi:10.1016/s0090-4295(00)00939-0 · Cited by 122
Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical Significance
SCHMITT, M., Jänicke, F., Moniwa, N., et al. (1992) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1992.373.2.611 · Cited by 122
Mucci, L. A., Tamimi, R. M., Λάγιου, Π., Trichopoulou, A., Benetou, V., Spanos, E., & Trichopoulos, D. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.02191.x · Cited by 121
Rabbani, S. A., Harakidas, P., Davidson, D. J., Henkin, J., & Mazar, A. P. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630615 · Cited by 121
Rabinovitz, I., Nagle, R. B., & Cress, A. E. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00118187 · Cited by 121
Cussenot, O., Berthon, P., Berger, R., Mowszowicz, I., Faille, A., Hojman, F., Teillac, P., Le Duc, A., & Calvo, F. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37953-3 · Cited by 121
The association of fatty acids with prostate cancer risk
Newcomer, L. M., King, I., Wicklund, K., & Stanford, J. L. (2001) · The Prostate · doi:10.1002/pros.1070 · Cited by 120
Physical activity and its relation to cancer risk: a prospective study of college alumni.
Lee, I. M., & Paffenbarger, R. S. (1994) · PubMed · Cited by 120
Connolly, J. M., & Rose, D. P. (1990) · The Prostate · doi:10.1002/pros.2990160304 · Cited by 120
Sweeney, P., Karashima, T., Kim, S. J., Kedar, D. J., Mian, B. M., HUANG, S. F., Baker, C. H., Fan, Z., Hicklin, D. J., Pettaway, C. A., et al. (2002) · PubMed · Cited by 120
Smoking history and cancer patient survival: a hospital cancer registry study.
Yu, G. P., Ostroff, J. S., Zhang, Z., Tang, J., & Schantz, S. P. (1997) · PubMed · Cited by 120
Geographic Patterns of Prostate Cancer in the United States
Blair, A., & Fraumeni, J. F. (1978) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/61.6.1379 · Cited by 119
Parr, C., & Jiang, W. G. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.4.857 · Cited by 118
Takahashi, S., Shan, A., Ritland, S., Delacey, K., Bostwick, D. G., Lieber, M. M., Thibodeau, S. N., & Jenkins, R. B. (1995) · PubMed · Cited by 117
Self-citationHamdy, F. C., Autzen, P., Robinson, M. C., et al. (1997) · PubMed · Cited by 117
Kimura, G., Kasuya, J., Giannini, S., Honda, Y., Mohan, S., Kawachi, M. H., Akimoto, M., & Fujita‐Yamaguchi, Y. (1996) · International Journal of Urology · doi:10.1111/j.1442-2042.1996.tb00628.x · Cited by 117
Witkowski, C. M., Rabinovitz, I., Nagle, R. B., Affinito, K. S., & Cress, A. E. (1993) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01215981 · Cited by 116
Expression of Fibroblast Growth Factors (FGFs) and FGF Receptors in Human Prostate
Ittman, M. M., & Mansukhani, A. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65376-x · Cited by 116
12(S)-HETE Enhancement of Prostate Tumor Cell Invasion: Selective Role of PKC
Liu, B., Maher, R. J., Hannun, Y. A., Porter, A. T., & Honn, K. V. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.15.1145 · Cited by 116
Schrauzer, G. N. (1992) · Biological Trace Element Research · doi:10.1007/bf02783992 · Cited by 116
Subbarayan, V., Sabichi, A. L., Llansa, N., Lippman, S. M., & Menter, D. G. (2001) · PubMed · Cited by 115
Pflug, B. R., Onoda, M., Lynch, J. H., & Djakiew, D. (1992) · PubMed · Cited by 115
Self-citationCleavage of β4 Integrin by Matrilysin
von Bredow, D. C., Nagle, R. B., Bowden, G. T., & Cress, A. E. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3711 · Cited by 115
Huebner, K., Isobe, M., Chao, M. V., Bothwell, M. A., Ross, A. H., Finan, J. B., Hoxie, J. A., Sehgal, A., Buck, C. R., & Lanahan, A. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1403 · Cited by 115
Prostate cancer and exposure to pesticides in agricultural settings
Settimi, L., Masina, A., Andrion, A., & Axelson, O. (2003) · International Journal of Cancer · doi:10.1002/ijc.10955 · Cited by 115
Even, M. D., Dhar, M., & Saal, F. S. V. (1992) · Reproduction · doi:10.1530/jrf.0.0960709 · Cited by 115
Busch, C., Hanssen, T. A., Wagener, C., & Öbrink, B. (2002) · Human Pathology · doi:10.1053/hupa.2002.32218 · Cited by 114
Tobacco Use and Prostate Cancer: 26-Year Follow-up of US Veterans
Hsing, A. W., McLaughlin, J. K., Hrubec, Z., Blot, W. J., & Fraumeni, J. F. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115910 · Cited by 114
Mohr, B. A., Feldman, H. A., Kalish, L. A., Longcope, C., & McKinlay, J. B. (2001) · Urology · doi:10.1016/s0090-4295(00)01116-x · Cited by 113
Nonneman, D., Ganjam, V. K., Welshons, W. V., & Saal, F. S. V. (1992) · Biology of Reproduction · doi:10.1095/biolreprod47.5.723 · Cited by 113
Stapleton, A. M. F., Zbell, P., Kattan, M. W., Yang, G., Wheeler, T. M., Scardino, P. T., & Thompson, T. C. (1998) · Cancer · Cited by 113
Danielpour, D., Kadomatsu, K., Anzano, M. A., et al. (1994) · PubMed · Cited by 112
Case‐control study of prostate cancer and socioeconomic factors
Yu, H., Harris, R. E., & Wynder, E. L. (1988) · The Prostate · doi:10.1002/pros.2990130407 · Cited by 112
Medical, life‐style, and occupational risk factors for prostate cancer
Checkoway, H., DiFerdinando, G. T., Hulka, B. S., et al. (1987) · The Prostate · doi:10.1002/pros.2990100111 · Cited by 112
Smoking and Fatal Prostate Cancer in a Large Cohort of Adult Men
Rodnguez, C., Tatham, L. M., Thun, M. J., Calle, E. E., & Heath, C. W. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009129 · Cited by 112
MacGrogan, D., Saint‐André, J., & Dicou, E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08451.x · Cited by 112
Ravindranath, N., Wion, D., Brachet, P., & Djakiew, D. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02199.x · Cited by 111
Self-citationFactor Analysis of International Cancer Mortality Data and per capita Food Consumption
Howell, M. A. (1974) · British Journal of Cancer · doi:10.1038/bjc.1974.75 · Cited by 111
Lau, K., Leav, I., & Ho, S. (1998) · Endocrinology · doi:10.1210/endo.139.1.5809 · Cited by 111
Self-citationGERSTENBLUTH, R. E., Seftel, A. D., MacLennan, G. T., Rao, R. N., Corty, E. W., Ferguson, K., & Resnick, M. I. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65140-3 · Cited by 111
Uzzo, R. G., Leavis, P. C., Hatch, W., Gabai, V. L., Dulin, N. O., Звартау, Н. Э., & Kolenko, V. M. (2002) · PubMed · Cited by 111
Siemiatycki, J., Richardson, L., Gerin, M. G., Goldberg, M. S., Dewar, R. A. D., Désy, M., Campbell, S., & Wacholder, S. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114232 · Cited by 111
VASECTOMY AND THE RISK OF PROSTATE CANCER
Rosenberg, L. A., Palmer, J. R., Zauber, A. G., et al. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115746 · Cited by 111
Familial factors affecting prostatic cancer risk and plasma sex-steroid levels
Wayne Meikle, A., Smith, J. A., & West, D. W. (1985) · The Prostate · doi:10.1002/pros.2990060202 · Cited by 110
Latent Effects of Pesticides and Toxic Substances On Sexual Differentiation of Rodents
Gray, L. E., & KELCE, W. R. (1996) · Toxicology and Industrial Health · doi:10.1177/074823379601200323 · Cited by 110
The etiology of prostate cancer: What does the epidemiology suggest?
Ross, R. K., Paganini‐Hill, A., & Henderson, B. E. (1983) · The Prostate · doi:10.1002/pros.2990040403 · Cited by 110
Vitamin A, β-Carotene, and the Risk of Cancer: A Prospective Study 2
Paganini‐Hill, A., Chao, A., Ross, R. K., & Henderson, B. E. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/79.3.443 · Cited by 110
Platz, E. A., Pollak, M., Rimm, E. B., et al. (1999) · PubMed · Cited by 110
Homocysteine, Oxidative Stress, and Vascular Disease
Welch, G. N., Upchurch, G. R., & Loscalzo, J. (1997) · Hospital Practice · doi:10.1080/21548331.1997.11443510 · Cited by 110
Diet, Androgens, Oxidative Stress and Prostate Cancer Susceptibility
Fleshner, N. E., & Klotz, L. H. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006118628183 · Cited by 109
Body mass and prostatic cancer: a prospective study.
Severson, R. K., Grove, J., Nomura, A. M. Y., & Stemmermann, G. N. (1988) · BMJ · doi:10.1136/bmj.297.6650.713 · Cited by 109
Expression of the Human Relaxin H1 Gene in the Decidua, Trophoblast, and Prostate*
HANSELL, D. J., Bryant‐Greenwood, G. D., & Greenwood, F. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-899 · Cited by 109
The PTEN Tumor Suppressor Protein Inhibits Tumor Necrosis Factor-induced Nuclear Factor κB Activity
Gustin, J. A., Maehama, T., Dixon, J. E., & Donner, D. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102559200 · Cited by 108
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines
Jongsma, J., Oomen, M. H., Noordzij, M. A., Romijn, J. C., van der Kwast, T., Schr�der, F. H., & van Steenbrugge, G. J. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000101)42:1<56::aid-pros7>3.0.co;2-p · Cited by 108
The results of a five-year early prostate cancer detection intervention
Mettlin, C. J., Murphy, G. P., Babaian, R. J., Chesley, A. E., Kane, R. A., Littrup, P. J., Mostofi, F. K., Ray, P. S., Shanberg, A. M., Toi, A., et al. (1996) · Cancer · Cited by 108
Yonou, H., Yokose, T., Kamijo, T., Kanomata, N., Hasebe, T., Nagai, K., Hatano, T., Ogawa, Y., & Ochiai, A. (2001) · PubMed · Cited by 108
Srkalović, G., Wittliff, J. L., & Schally, A. V. (1990) · PubMed · Cited by 107
Xie, H., Turner, T., Wang, M., Singh, R. K., Siegal, G. P., & Wells, A. H. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00118180 · Cited by 107
Slattery, M. L., & West, D. W. (1993) · Cancer Causes & Control · doi:10.1007/bf00052432 · Cited by 107
Nesterov, A., Ivashchenko, Y., & Kraft, A. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205151 · Cited by 107
Bennett, C. L., Price, D. K., Kim, S. P., Liu, D., Jovanovic, B. D., Nathan, D. P., Johnson, M. E., Montgomery, J. S., Cude, K. J., Brockbank, J. C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.085 · Cited by 107
Role of Retinoids in Differentiation and Carcinogenesis *
Sporn, M. B., & Roberts, A. B. (1984) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/73.6.1381 · Cited by 107
A review of physical activity and prostate cancer risk
Friedenreich, C. M., & Thune, I. (2001) · Cancer Causes & Control · doi:10.1023/a:1011210121901 · Cited by 106
Differential expression of 5α-reductase isoenzymes in the human prostate and prostatic carcinomas
Bonkhoff, H., Stein, U., Aumüller, G., & REMBERGER, K. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199610)29:4<261::aid-pros7>3.0.co;2-e · Cited by 106
Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review
Kaaks, R., Lukanova, A., & Sommersberg, B. (2000) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500421 · Cited by 105
Liu, Y., Jovanovic, B. D., Pins, M., Lee, C., & Bergan, R. C. (2002) · Oncogene · doi:10.1038/sj.onc.1206117 · Cited by 105
Dolbeare, F. A. (1996) · The Histochemical Journal · doi:10.1007/bf02331377 · Cited by 105
Role of Eicosanoids in Prostate Cancer Progression
Nie, D., Che, M., Grignon, D. J., Tang, K., & Honn, K. V. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015579209850 · Cited by 105
HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization
Ross, J. S., Sheehan, C., Hayner‐Buchan, A., Ambros, R. A., Kallakury, B., Kaufman, R. P., Fisher, H. A. �., & Muraca, P. J. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90157-x · Cited by 105
Fox, W. D., Higgins, B., Maiese, K., Drobnjak, M., Cordon‐Cardo, C., Scher, H. I., & Agus, D. B. (2002) · PubMed · Cited by 105
Sato, N., Gleave, M. E., Bruchovsky, N., Rennie, P. S., Beraldi, E., & Sullivan, L. D. (1997) · PubMed · Cited by 103
Liu, X. H., Wiley, H. S., & Meikle, A. W. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263129 · Cited by 103
Coughlin, S. S., Neaton, J. D., & Sengupta, A. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008663 · Cited by 103
Shen, R., Su, Z. Z., Olsson, C. A., & Fisher, P. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6778 · Cited by 103
Stage C Prostatic Adenocarcinoma: Flow Cytometric Nuclear DNA Ploidy Analysis
Nativ, O., WINKLER, H. Z., Raz, Y., Therneau, T. M., Farrow, G. M., MYERS, R. P., Zincke, H., & Lieber, M. M. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61218-x · Cited by 103
Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans.
Mohan, R. R., Challa, A., Gupta, S., Bostwick, D. G., Ahmad, N., Agarwal, R., Marengo, S. R., Amini, S. B., Paras, F. A., MacLennan, G. T., et al. (1999) · PubMed · Cited by 103
Self-citationExpression of a Trk high affinity nerve growth factor receptor in the human prostate
Pflug, B. R., Dionne, C. A., Kaplan, D. R., Lynch, J. H., & Djakiew, D. (1995) · Endocrinology · doi:10.1210/endo.136.1.7828539 · Cited by 103
Self-citationEarly Gene Responses to Transforming Growth Factor-β in Cells Lacking Growth-Suppressive RB Function
Zentella‐Dehesa, A., Weis, F. M., Ralph, D. A., Laiho, M., & Massagué, J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4952 · Cited by 103
Degeorges, A., Tatoud, R., Fauvel-Lafève, F., Podgorniak, M.-P., Millot, G., de Crémoux, P., & Calvo, F. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961009)68:2<207::aid-ijc12>3.0.co;2-7 · Cited by 102
Workgroup I: Rodent models of prostate cancer
Lucia, M. S., Bostwick, D. G., Bosland, M. C., Cockett, A. T. �., Knapp, D. W., Leav, I., Pollard, M., Rinker-Schaeffer, C. W., Shirai, T., & Watkins, B. A. (1998) · The Prostate · Cited by 102
Self-citationVukanovic, J., & Isaacs, J. T. (1995) · PubMed · Cited by 102
Dietary fat intake and prostate cancer risk: a case–control study in Spain
Ramon, J. M., Bou, R., Lecumberri, S. R., Alkiza, M. E., Jacas, M., Ribes, J., & Oromí, J. (2000) · Cancer Causes & Control · doi:10.1023/a:1008924116552 · Cited by 101
Cancer of the Prostate: Epidemiology and Aetiology
Zaridze, D. G., & Boyle, P. (1987) · British Journal of Urology · doi:10.1111/j.1464-410x.1987.tb04862.x · Cited by 101
Epidemiologic study of prostatic cancer: preliminary report.
Lm, S., Mandel, J., Blackard, C. E., et al. (1977) · PubMed · Cited by 101
Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression
Webber, M. M., QUADER, S. T. A., Kleinman, H. K., Bello‐DeOcampo, D., Storto, P. D., Bice, G., de Calaca, W. M., & Williams, D. E. (2001) · The Prostate · doi:10.1002/pros.1041 · Cited by 100
Sebo, T. J., Cheville, J. C., Riehle, D., Lohse, C. M., Pankratz, V. S., Myers, R. P., Blute, M. L., & Zincke, H. (2001) · Cancer · Cited by 100
Mechanisms of Bcl-2 family protein function and dysfunction in health and disease.
Reed, J. C. (1996) · PubMed · Cited by 99
Gmyrek, G. A., Walburg, M., Webb, C. P., Yu, H. I., You, X., Vaughan, E. D., Woude, G. F. V., & Knudsen, B. S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61729-4 · Cited by 99
Yamada, Y., Watanabe, M., Murata, M., Yamanaka, M., Kubota, Y., Itô, H., Katoh, T., Kawamura, J., Yatani, R., & Shiraishi, T. (2001) · International Journal of Cancer · Cited by 99
Retinoblastoma gene mutations in primary human prostate cancer
Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H., & Shuin, T. (1995) · The Prostate · doi:10.1002/pros.2990270604 · Cited by 98
Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay.
Stéfani, E. D., Deneo‐Pellegrini, H., Boffetta, P., Ronco, Á. L., & Mendilaharsu, M. (2000) · PubMed · Cited by 98
Cloning and characterization of androgen-dependent mRNA from rat ventral prostate.
Parker, M. G., White, R., & Williams, J. G. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43674-5 · Cited by 97
Steiner, H., Godoy‐Tundidor, S., Rogatsch, H., Berger, A. P., Fuchs, D., Comuzzi, B., Bartsch, G. H., Hobisch, A., & Čulig, Z. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63859-x · Cited by 97
Jungwirth, A., Pinski, J., Galvan, G., Halmos, G. B., Szepesházi, K., Gai, R. Z., Groot, K., Vadillo-Buenfil, M., & Schally, A. V. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00072-5 · Cited by 97
VATTEN, L. J., Ursin, G., Ross, R. K., Stanczyk, F. Z., Løbo, R. A., Harvei, S., & Jellum, E. (1997) · PubMed · Cited by 97
Ho, P. J., & Baxter, R. C. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1100922.x · Cited by 97
Kasof, G. M., Lu, J. J., Liu, D., Speer, B. S., Mongan, K. N., Gomes, B. C., & Lorenzi, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204985 · Cited by 96
Vitamin D Receptor Genotype and the Risk of Bone Fractures in Women
Feskanich, D., Hunter, D. J., Willett, W. C., Hankinson, S. E., Hollis, B. W., Hough, H., Kelsey, K. T., & Colditz, G. A. (1998) · Epidemiology · doi:10.1097/00001648-199809000-00011 · Cited by 96
Co-ordinated changes in expression of cell adhesion molecules in prostate cancer
Murant, S. J., Handley, J., Stower, M. J., Reid, N., Cussenot, O., & Maitland, N. J. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00418-2 · Cited by 95
Androgen receptors in prostate cancer
Bentel, J. M., & Tilley, W. D. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1510001 · Cited by 95
EVIDENCE OF AN INHIBITORY EFFECT OF DIET AND EXERCISE ON PROSTATE CANCER CELL GROWTH
Tymchuk, C. N., Barnard, R. J., Heber, D., & Aronson, W. J. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65943-5 · Cited by 95
Concerning a familial association between breast cancer and both prostatic and uterine malignancies
Thiessen, E. U. (1974) · Cancer · Cited by 95
Neuroendocrine Differentiation in Metastatic Prostatic Adenocarcinoma
Aprikian, A. G., Cordon‐Cardo, C., Fair, W. R., Zhang, Z., Bazinet, M., Hamdy, S. M., & Reuter, V. E. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)35121-2 · Cited by 95
Krygier, S., & Djakiew, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.10160 · Cited by 94
Self-citationDalal, R., & Djakiew, D. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00165-2 · Cited by 94
Self-citationGraham, C. W., Lynch, J. H., & Djakiew, D. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37590-0 · Cited by 93
Self-citationChoi, Y., Henrard, D., Lee, I., & Ross, S. R. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3013-3019.1987 · Cited by 92
Rabbani, S. A., & Gladu, J. (2002) · PubMed · Cited by 92
Elo, J. P., Härkönen, P. K., Kyllönen, A. P., Lukkarinen, O. A., POUTANEN, M. H., Vihko, R., & Vihko, P. (1997) · PubMed · Cited by 92
Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteins
Heidebrecht, H. J., Buck, F., Haas, K., Wacker, H. H., & Parwaresch, R. M. (1996) · Cell Proliferation · doi:10.1111/j.1365-2184.1996.tb00984.x · Cited by 92
Growth of an androgen‐sensitive human prostate cancer cell line, LNCaP, in nude mice
LIM, D. J., Liu, X., Sutkowski, D. M., Braun, E. J., Lee, C., & Kozlowski, J. M. (1993) · The Prostate · doi:10.1002/pros.2990220203 · Cited by 92
Hailey, J., Maxwell, E., Koukouras, K., Bishop, W. R., Pachter, J. A., & Wang, Y. (2002) · PubMed · Cited by 92
Kaighn, M. E., Reddel, R. R., Lechner, J. F., Peehl, D. M., Camalier, R. F., Brash, D. E., Saffiotti, U., & Harris, C. C. (1989) · PubMed · Cited by 92
Risk factors for prostate cancer.
Key, T. J. (1995) · PubMed · Cited by 92
Human prostate cancer model: Roles of growth factors and extracellular matrices
Chung, L. W. K., Li, W., Gleave, M. E., Hsieh, J., Wu, H., Sikes, R. A., Zhau, H. E., Bandyk, M., Logothetis, C. J., Rubin, J. S., et al. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240501222 · Cited by 91
Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
Takahashi, H., Furusato, M., Allsbrook, W. C., Nishii, H., Wakui, S., Barrett, J. C., & Boyd, J. A. (1995) · PubMed · Cited by 91
Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates
Masai, M., Sumiya, H., Akimoto, S., Yatani, R., Chang, C., Liao, S., & Shimazaki, J. (1990) · The Prostate · doi:10.1002/pros.2990170405 · Cited by 91
Serum androgens and prostate cancer.
Nomura, A. M. Y., Stemmermann, G. N., Chyou, P.-H., Henderson, B. E., & Stanczyk, F. Z. (1996) · PubMed · Cited by 91
Brown, R. S. D., Edwards, J., Doǧan, A., Payne, H. A., Harland, S. J., Bartlett, J. M. S., & Masters, J. R. (2002) · The Journal of Pathology · doi:10.1002/path.1206 · Cited by 90
K-ras activation andras p21 expression in latent prostatic carcinoma in Japanese men
Konishi, N., Enomoto, T., Buzard, G. S., Ohshima, M., Ward, J. M., & Rice, J. M. (1992) · Cancer · doi:10.1002/1097-0142(19920501)69:9<2293::aid-cncr2820690915>3.0.co;2-o · Cited by 90
Pollard, M., & Luckert, P. H. (1986) · Cancer Letters · doi:10.1016/0304-3835(86)90123-0 · Cited by 90
Seslar, S. P., Nakamura, T., & Byers, S. W. (1993) · PubMed · Cited by 90
HEPSIN inhibits cell growth/invasion in prostate cancer cells.
Srikantan, V., Valladares, M., Rhim, J. S., Moul, J. W., & Srivastava, S. K. (2002) · PubMed · Cited by 90
Watson, C. S., Pappas, T. C., & Gametchu, B. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s741 · Cited by 89
Rohrmann, S., Roberts, W. W., Walsh, P. C., & Platz, E. A. (2003) · The Prostate · doi:10.1002/pros.10211 · Cited by 89
Hawk, E., Breslow, R. A., & Graubard, B. I. (2000) · PubMed · Cited by 88
Facher, E. A., Becich, M. J., Deka, A., & Law, J. C. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2424::aid-cncr19>3.0.co;2-t · Cited by 88
Expression and Regulation of Steroid 5α-Reductase 2 in Prostate Disease
Silver, R. I., Wiley, E. L., Davis, D. L., Thigpen, A. E., Russell, D. W., & McConnell, J. D. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32757-x · Cited by 88
Meta‐analyses of prostate cancer and farming
Keller‐Byrne, J. E., Khuder, S., & Schaub, E. A. (1997) · American Journal of Industrial Medicine · Cited by 88
Phytoestrogens and prostate cancer: possible preventive role
Stephens, F. O., & Unit, O. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb138812.x · Cited by 87
Segawa, N., Mori, I., Utsunomiya, H., Nakamura, M., Nakamura, Y., Shan, L., Kakudo, K., & Katsuoka, Y. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01226.x · Cited by 87
Goodman, G. E., Schaffer, S., Bankson, D. D., Hughes, M. P., & Omenn, G. S. (2001) · PubMed · Cited by 87
Research works printed but not linked: 902
- Oishi, 1995, Cancer Surv., 23, 267
- Parkin, 1992, IARC Sci Publ., 120, 45
- Doherty, 1996, Br J Hosp Med., 55, 104
- Morrison, 1995, Can J Public Health., 86, 274
- Dijkman, 1996, Eur Urol., 30, 281, 10.1159/000474185 · doi:10.1159/000474185
- Wingo, 1998, Cancer Epidemiol Biomarkers Prev., 7, 271
- Merrill, 1996, J Natl Cancer Inst., 88, 1683, 10.1093/jnci/88.22.1683 · doi:10.1093/jnci/88.22.1683
- Mettlin, 1996, Cancer., 77, 150, 10.1002/(SICI)1097-0142(19960101)77:1<150::AID-CNCR25>3.0.CO;2-3 · doi:10.1002/(sici)1097-0142(19960101)77:1<150::aid-cncr25>3.0.co;2-3
- Brawley, 1997, Cancer., 80, 1857, 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3 · doi:10.1002/(sici)1097-0142(19971101)80:9<1857::aid-cncr26>3.0.co;2-3
- Wingo, 1997, Cancer., 80, 1810, 10.1002/(SICI)1097-0142(19971101)80:9<1810::AID-CNCR19>3.0.CO;2-8 · doi:10.1002/(sici)1097-0142(19971101)80:9<1810::aid-cncr19>3.0.co;2-8
- Levy, 1993, CMAJ., 149, 617
- Smart, 1997, CA Cancer J Clin., 47, 134, 10.3322/canjclin.47.3.134 · doi:10.3322/canjclin.47.3.134
- Pienta, 1995, Urology., 45, 93, 10.1016/S0090-4295(95)96996-9 · doi:10.1016/s0090-4295(95)96996-9
- Dhom, 1983, J Cancer Res Clin Oncol., 106, 210, 10.1007/BF00402610 · doi:10.1007/bf00402610
- Polednak, 1997, Cancer., 79, 99, 10.1002/(SICI)1097-0142(19970101)79:1<99::AID-CNCR14>3.0.CO;2-1 · doi:10.1002/(sici)1097-0142(19970101)79:1<99::aid-cncr14>3.0.co;2-1
- Newman, 1996, Radiol Technol., 68, 39
- Bostwick, 1992, Cancer., 70, 291, 10.1002/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4 · doi:10.1002/1097-0142(19920701)70:1+<291::aid-cncr2820701317>3.0.co;2-4
- Partin, 1994, Urology., 44, 646, 10.1016/S0090-4295(94)80197-5 · doi:10.1016/s0090-4295(94)80197-5
- Bostwick, 2000, Curr Urol Rep., 1, 65, 10.1007/s11934-000-0037-x · doi:10.1007/s11934-000-0037-x
- Bostwick, 1987, Cancer., 59, 788, 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I · doi:10.1002/1097-0142(19870215)59:4<788::aid-cncr2820590421>3.0.co;2-i
- Montironi, 1996, Eur Urol., 30, 133, 10.1159/000474162 · doi:10.1159/000474162
- Allam, 1996, Mod Pathol., 9, 742
- Qian, 1997, Hum Pathol., 28, 143, 10.1016/S0046-8177(97)90097-6 · doi:10.1016/s0046-8177(97)90097-6
- Feneley, 1997, Prostate Cancer Prostatic Dis., 1, 79, 10.1038/sj.pcan.4500210 · doi:10.1038/sj.pcan.4500210
- Sakr, 1997, Eur Urol., 32, 15
- Keetch, 1995, J Urol., 154, 347, 10.1016/S0022-5347(01)67044-7 · doi:10.1016/s0022-5347(01)67044-7
- Raviv, 1996, Acta Urol Belgium., 64, 11
- Rovner, 1997, J Urol., 158, 138, 10.1097/00005392-199707000-00042 · doi:10.1097/00005392-199707000-00042
- Davidson, 1995, J Urol., 154, 1295, 10.1016/S0022-5347(01)66840-X · doi:10.1016/s0022-5347(01)66840-x
- Shepherd, 1996, J Urol., 156, 460, 10.1016/S0022-5347(01)65881-6 · doi:10.1016/s0022-5347(01)65881-6
- Langer, 1996, J Urol., 155, 228, 10.1016/S0022-5347(01)66601-1 · doi:10.1016/s0022-5347(01)66601-1
- Bostwick, 1996, Eur Urol., 30, 145, 10.1159/000474164 · doi:10.1159/000474164
- Bostwick, 1996, Cancer., 78, 330, 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W · doi:10.1002/(sici)1097-0142(19960715)78:2<330::aid-cncr22>3.0.co;2-w
- Ferguson, 1994, Urology., 44, 91, 10.1016/S0090-4295(94)80015-4 · doi:10.1016/s0090-4295(94)80015-4
- Aquilina, 1997, J Natl Cancer Inst., 89, 689, 10.1093/jnci/89.10.689 · doi:10.1093/jnci/89.10.689
- Colombel, 1993, Am J Pathol., 143, 390
- Goldstein, 1995, Hum Pathol., 26, 887, 10.1016/0046-8177(95)90012-8 · doi:10.1016/0046-8177(95)90012-8
- Saez, 1998, Mod Pathol., 11, 1193
- Papadopoulos, 2001, Clin Cancer Res., 7, 1533
- Kirschenbaum, 1999, Mol Urol., 3, 163
- Molberg, 1994, Am J Clin Pathol., 101, 266, 10.1093/ajcp/101.3.266 · doi:10.1093/ajcp/101.3.266
- Shah, 2001, Arch Pathol Lab Med., 125, 141, 10.5858/2001-125-0141-HAHCOS · doi:10.5858/2001-125-0141-hahcos
- Bostwick, 1995, Arch Pathol Lab Med., 119, 444
- Varma, 2002, Arch Pathol Lab Med., 126, 554, 10.5858/2002-126-0554-MCFTDO · doi:10.5858/2002-126-0554-mcftdo
- Egan, 1997, Am J Surg Pathol., 21, 931, 10.1097/00000478-199708000-00007 · doi:10.1097/00000478-199708000-00007
- Zhou, 2001, Am J Clin Pathol., 115, 39, 10.1309/2APJ-YKBD-97EH-67GW · doi:10.1309/2apj-ykbd-97eh-67gw
- Bonin, 1997, Cancer., 79, 75, 10.1002/(SICI)1097-0142(19970101)79:1<75::AID-CNCR11>3.0.CO;2-3 · doi:10.1002/(sici)1097-0142(19970101)79:1<75::aid-cncr11>3.0.co;2-3
- Ozcan, 2001, Eur Urol., 40, 308, 10.1159/000049791 · doi:10.1159/000049791
- D'Amico, 2001, J Urol., 165, 126, 10.1097/00005392-200101000-00031 · doi:10.1097/00005392-200101000-00031
- Nelson, 2002, Urology., 59, 740, 10.1016/S0090-4295(02)01654-0 · doi:10.1016/s0090-4295(02)01654-0
- O'Malley, 2002, Urology., 59, 85, 10.1016/S0090-4295(01)01486-8 · doi:10.1016/s0090-4295(01)01486-8
- Freedland, 2002, J Urol., 167, 516, 10.1016/S0022-5347(01)69076-1 · doi:10.1016/s0022-5347(01)69076-1
- Sebo, 2001, Cancer., 91, 2196, 10.1002/1097-0142(20010601)91:11<2196::AID-CNCR1249>3.0.CO;2-# · doi:10.1002/1097-0142(20010601)91:11<2196::aid-cncr1249>3.0.co;2-#
- Merrick, 2002, Cancer J., 8, 79, 10.1097/00130404-200201000-00014 · doi:10.1097/00130404-200201000-00014
- Bahnson, 1989, Prostate., 15, 149, 10.1002/pros.2990150208 · doi:10.1002/pros.2990150208
- Montironi, 1993, Virchows Arch A Pathol Anat Histopathol., 422, 185, 10.1007/BF01621801 · doi:10.1007/bf01621801
- Weidner, 1993, Am J Pathol., 143, 401
- Brawer, 1994, Cancer., 73, 678, 10.1002/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO;2-6 · doi:10.1002/1097-0142(19940201)73:3<678::aid-cncr2820730329>3.0.co;2-6
- Hall, 1994, Urology., 44, 869, 10.1016/S0090-4295(94)80173-8 · doi:10.1016/s0090-4295(94)80173-8
- Vesalainen, 1994, Anticancer Res., 14, 709
- Epstein, 2000, Urology., 56, 283, 10.1016/S0090-4295(00)00640-3 · doi:10.1016/s0090-4295(00)00640-3
- Silberman, 1997, Cancer., 79, 772, 10.1002/(SICI)1097-0142(19970215)79:4<772::AID-CNCR14>3.0.CO;2-X · doi:10.1002/(sici)1097-0142(19970215)79:4<772::aid-cncr14>3.0.co;2-x
- de la Taille, 2000, Am J Clin Pathol., 113, 555, 10.1309/02W2-KE50-PKEF-G2G4 · doi:10.1309/02w2-ke50-pkef-g2g4
- Stamey, 1999, JAMA., 281, 1395, 10.1001/jama.281.15.1395 · doi:10.1001/jama.281.15.1395
- van den Ouden, 1998, Urol Int., 60, 17, 10.1159/000030197 · doi:10.1159/000030197
- McNeal, 1996, Am J Surg Pathol., 20, 1351, 10.1097/00000478-199611000-00006 · doi:10.1097/00000478-199611000-00006
- Mehta, 2001, Clin Cancer Res., 7, 81
- Whittemore, 1995, Am J Epidemiol., 141, 732, 10.1093/oxfordjournals.aje.a117495 · doi:10.1093/oxfordjournals.aje.a117495
- Klein, 1998, Prostate Cancer Prostatic Dis., 1, 297, 10.1038/sj.pcan.4500257 · DOI
- Damber, 1998, Int J Cancer., 78, 293, 10.1002/(SICI)1097-0215(19981029)78:3<293::AID-IJC5>3.0.CO;2-Q · doi:10.1002/(sici)1097-0215(19981029)78:3<293::aid-ijc5>3.0.co;2-q
- Bratt, 1999, Eur J Cancer., 35, 272, 10.1016/S0959-8049(98)00358-X · doi:10.1016/s0959-8049(98)00358-x
- Cerhan, 1999, Cancer Epidemiol Biomarkers Prev., 8, 53
- Lightfoot, 2000, Ann Epidemiol., 10, 470, 10.1016/S1047-2797(00)00112-5 · doi:10.1016/s1047-2797(00)00112-5
- Kalish, 2000, Urology., 56, 803, 10.1016/S0090-4295(00)00780-9 · DOI
- Kotsis, 2002, J Urol., 167, 1659, 10.1016/S0022-5347(05)65173-7 · doi:10.1016/s0022-5347(05)65173-7
- Cotter, 2002, Prostate., 50, 216, 10.1002/pros.10051 · doi:10.1002/pros.10051
- Stone, 2003, Ethn Dis., 13, 233
- Gronberg, 1999, Cancer., 86, 477, 10.1002/(SICI)1097-0142(19990801)86:3<477::AID-CNCR16>3.0.CO;2-K · doi:10.1002/(sici)1097-0142(19990801)86:3<477::aid-cncr16>3.0.co;2-k
- Schuurman, 1999, Epidemiology., 10, 192, 10.1097/00001648-199903000-00020 · doi:10.1097/00001648-199903000-00020
- McLellan, 1995, CMAJ., 153, 895
- Staples, 2003, Cancer Causes Control., 14, 161, 10.1023/A:1023073203467 · doi:10.1023/a:1023073203467
- Matikainen, 1999, Clin Cancer Res., 5, 1275
- Thiessen, 1974, Cancer., 34, 1102, 10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5 · doi:10.1002/1097-0142(197410)34:4<1102::aid-cncr2820340421>3.0.co;2-5
- Anderson, 1992, J Natl Cancer Inst., 84, 1114, 10.1093/jnci/84.14.1114 · doi:10.1093/jnci/84.14.1114
- Andrieu, 1991, Eur J Cancer., 27, 244, 10.1016/0277-5379(91)90506-9 · doi:10.1016/0277-5379(91)90506-9
- Henderson, 1982, Cancer Res., 42, 3232
- Ghanadian, 1979, Br J Cancer., 39, 696, 10.1038/bjc.1979.122 · doi:10.1038/bjc.1979.122
- Vatten, 1997, Cancer Epidemiol Biomarkers Prev., 6, 967
- Nomura, 1996, Cancer Epidemiol Biomarkers Prev., 5, 621
- Guess, 1997, Cancer Epidemiol Biomarkers Prev., 6, 21
- Chang, 2001, Prostate., 46, 62, 10.1002/1097-0045(200101)46:1<62::AID-PROS1009>3.0.CO;2-V · doi:10.1002/1097-0045(200101)46:1<62::aid-pros1009>3.0.co;2-v
- Stattin, 2001, J Clin Endocrinol Metab., 86, 1341
- Ross, 1986, J Natl Cancer Inst., 76, 45
- Barrett-Connor, 1990, Cancer Res., 50, 169
- Jackson, 1981, Progr Clin Biol Res., 53, 111
- Modugno, 2001, Clin Cancer Res., 7, 3092
- Haenszel, 1968, J Natl Cancer Inst., 40, 43
- Locke, 1980, J Natl Cancer Inst., 65, 1149
- Stellman, 1994, Cancer., 73, 1270, 10.1002/1097-0142(19940215)73:4<1270::AID-CNCR2820730423>3.0.CO;2-Y · doi:10.1002/1097-0142(19940215)73:4<1270::aid-cncr2820730423>3.0.co;2-y
- Merrill, 2000, Urology., 55, 730, 10.1016/S0090-4295(99)00564-6 · doi:10.1016/s0090-4295(99)00564-6
- Abdalla, 1998, Semin Urol Oncol., 16, 207
- Asbell, 2000, J Natl Med Assoc., 92, 445
- Zhang, 2000, J Urol., 163, 131, 10.1016/S0022-5347(05)67988-8 · doi:10.1016/s0022-5347(05)67988-8
- Fowler, 2000, J Urol., 163, 1467, 10.1016/S0022-5347(05)67644-6 · doi:10.1016/s0022-5347(05)67644-6
- Wu, 2001, Cancer Epidemiol Biomarkers Prev., 10, 533
- Reichardt, 1995, Cancer Res., 55, 3973
- Platz, 1999, Cancer Epidemiol Biomarkers Prev., 8, 1107
- Winter, 2001, Urology., 58, 614, 10.1016/S0090-4295(01)01273-0 · doi:10.1016/s0090-4295(01)01273-0
- Ekman, 1999, Prostate., 39, 262, 10.1002/(SICI)1097-0045(19990601)39:4<262::AID-PROS6>3.0.CO;2-P · doi:10.1002/(sici)1097-0045(19990601)39:4<262::aid-pros6>3.0.co;2-p
- Corder, 1995, Cancer Epidemiol Biomarkers Prev., 4, 655
- Yamada, 2001, Int J Cancer., 92, 683, 10.1002/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4 · doi:10.1002/1097-0215(20010601)92:5<683::aid-ijc1255>3.0.co;2-4
- Leadon, 1990, Health Phys., 59, 15, 10.1097/00004032-199007000-00001 · doi:10.1097/00004032-199007000-00001
- Statland, 1992, Clin Chem., 38, 1587
- Palmiter, 1987, Experientia., 52, 63
- Yu, 1994, Cancer., 73, 596, 10.1002/1097-0142(19940201)73:3<596::AID-CNCR2820730316>3.0.CO;2-N · doi:10.1002/1097-0142(19940201)73:3<596::aid-cncr2820730316>3.0.co;2-n
- Hietanen, 1994, Eur J Clin Nutr., 48, 575
- Hietanen, 1991, Carcinogenesis., 12, 591, 10.1093/carcin/12.4.591 · doi:10.1093/carcin/12.4.591
- Clark, 1996, JAMA., 276, 1957, 10.1001/jama.1996.03540240035027 · DOI · Paper page
- Han, 1995, Carcinogenesis., 16, 951, 10.1093/carcin/16.4.951 · doi:10.1093/carcin/16.4.951
- Schuurman, 1999, Cancer., 86, 1019, 10.1002/(SICI)1097-0142(19990915)86:6<1019::AID-CNCR18>3.0.CO;2-H · doi:10.1002/(sici)1097-0142(19990915)86:6<1019::aid-cncr18>3.0.co;2-h
- Berg, 1975, Cancer Res., 35, 3345
- Blair, 1978, J Natl Cancer Inst., 61, 1379
- Ohno, 1988, Cancer Res., 48, 1331
- Mettlin, 1989, Cancer., 64, 605, 10.1002/1097-0142(19890801)64:3<605::AID-CNCR2820640307>3.0.CO;2-I · doi:10.1002/1097-0142(19890801)64:3<605::aid-cncr2820640307>3.0.co;2-i
- Hayes, 1999, Cancer Epidemiol Biomarkers Prev., 8, 25
- Graham, 1983, J Natl Cancer Inst., 70, 687
- Ross, 1987, J Natl Cancer Inst., 78, 869
- Severson, 1989, Cancer Res., 49, 1857
- Mills, 1989, Cancer., 64, 598, 10.1002/1097-0142(19890801)64:3<598::AID-CNCR2820640306>3.0.CO;2-6 · doi:10.1002/1097-0142(19890801)64:3<598::aid-cncr2820640306>3.0.co;2-6
- Hirayama, 1979, Natl Cancer Inst Monogr., 53, 149
- Hsing, 1990, Cancer Res., 50, 6836
- De Stefani, 2000, Cancer Epidemiol Biomarkers Prev., 9, 335
- Harvei, 1997, Int J Cancer., 71, 545, 10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U · doi:10.1002/(sici)1097-0215(19970516)71:4<545::aid-ijc7>3.0.co;2-u
- Bishop, 1988, Immunogenetics., 28, 184, 10.1007/BF00375858 · doi:10.1007/bf00375858
- Sporn, 1984, J Natl Cancer Inst., 73, 1381
- Kummet, 1983, Semin Oncol., 10, 281
- Olsen, 1996, Ugeskr Laeger., 158, 3171
- Kolonel, 1987, Cancer Res., 47, 2982
- Ellison, 1998, Chron Dis Can., 19, 1
- Paganini-Hill, 1987, J Natl Cancer Inst., 79, 443
- Hayes, 1988, Cancer., 62, 2021, 10.1002/1097-0142(19881101)62:9<2021::AID-CNCR2820620925>3.0.CO;2-R · doi:10.1002/1097-0142(19881101)62:9<2021::aid-cncr2820620925>3.0.co;2-r
- Reichman, 1990, Cancer Res., 50, 2311
- Wald, 1986, Br J Cancer., 54, 957, 10.1038/bjc.1986.267 · doi:10.1038/bjc.1986.267
- Nomura, 1997, Cancer Epidemiol Biomarkers Prev., 6, 487
- Cook, 1999, Cancer., 86, 1783, 10.1002/(SICI)1097-0142(19991101)86:9<1783::AID-CNCR21>3.0.CO;2-N · doi:10.1002/(sici)1097-0142(19991101)86:9<1783::aid-cncr21>3.0.co;2-n
- Lu, 2001, Cancer Epidemiol Biomarkers Prev., 10, 749
- Hirayama, 1986, Gan No Rinsho., 32, 610
- Clinton, 1999, Cancer., 86, 1629, 10.1002/(SICI)1097-0142(19991101)86:9<1629::AID-CNCR1>3.0.CO;2-4 · doi:10.1002/(sici)1097-0142(19991101)86:9<1629::aid-cncr1>3.0.co;2-4
- Eichholzer, 1999, Prostate., 38, 189, 10.1002/(SICI)1097-0045(19990215)38:3<189::AID-PROS3>3.0.CO;2-N · doi:10.1002/(sici)1097-0045(19990215)38:3<189::aid-pros3>3.0.co;2-n
- Schwartz, 1990, Anticancer Res., 10, 1307
- Corder, 1993, Cancer Epidemiol Biomarkers Prev., 2, 467
- Peehl, 1999, Eur Urol., 35, 392, 10.1159/000019914 · doi:10.1159/000019914
- Suzuki, 2003, Int J Urol., 10, 261, 10.1046/j.1442-2042.2003.00617.x · doi:10.1046/j.1442-2042.2003.00617.x
- Schwartz, 1998, Cancer Epidemiol Biomarkers Prev., 7, 391
- Gann, 1996, Cancer Epidemiol Biomarkers Prev., 5, 121
- Schwartz, 1994, Anticancer Res., 14, 1077
- Chan, 1999, Cancer Epidemiol Biomarkers Prev., 8, 893
- Liang, 1999, Prostate., 40, 200, 10.1002/(SICI)1097-0045(19990801)40:3<200::AID-PROS8>3.0.CO;2-3 · doi:10.1002/(sici)1097-0045(19990801)40:3<200::aid-pros8>3.0.co;2-3
- Feustel, 1986, Prostate., 8, 75, 10.1002/pros.2990080109 · doi:10.1002/pros.2990080109
- Leake, 1984, Acta Endocrinol (Copenhagen)., 105, 281, 10.1530/acta.0.1050281 · doi:10.1530/acta.0.1050281
- Whelan, 1983, Br J Urol., 55, 525, 10.1111/j.1464-410X.1983.tb03362.x · doi:10.1111/j.1464-410x.1983.tb03362.x
- Chirulescu, 1987, Med Interne., 25, 257
- Ogunlewe, 1989, Cancer., 63, 1388, 10.1002/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M · doi:10.1002/1097-0142(19890401)63:7<1388::aid-cncr2820630725>3.0.co;2-m
- Lekili, 1991, Int Urol Nephrol., 23, 151, 10.1007/BF02549712 · doi:10.1007/bf02549712
- McCallum, 1988, Br J Urol., 62, 565, 10.1111/j.1464-410X.1988.tb04427.x · doi:10.1111/j.1464-410x.1988.tb04427.x
- Feustel, 1989, Urol Res., 17, 41
- Tvedt, 1989, Prostate., 15, 41, 10.1002/pros.2990150105 · doi:10.1002/pros.2990150105
- Elghany, 1990, Epidemiology., 1, 107, 10.1097/00001648-199003000-00005 · doi:10.1097/00001648-199003000-00005
- Goodman, 2001, Cancer Epidemiol Biomarkers Prev., 10, 1069
- Nomura, 2000, Cancer Epidemiol Biomarkers Prev., 9, 883
- Grant, 1999, Altern Med Rev., 4, 162
- Rodriguez, 2003, Cancer Epidemiol Biomarkers Prev., 12, 597
- Balaji, 2001, Prostate., 48, 265, 10.1002/pros.1106 · doi:10.1002/pros.1106
- Sung, 1999, Cancer., 86, 484, 10.1002/(SICI)1097-0142(19990801)86:3<484::AID-CNCR17>3.0.CO;2-P · doi:10.1002/(sici)1097-0142(19990801)86:3<484::aid-cncr17>3.0.co;2-p
- Hsieh, 1999, Int J Cancer., 80, 699, 10.1002/(SICI)1097-0215(19990301)80:5<699::AID-IJC12>3.0.CO;2-7 · doi:10.1002/(sici)1097-0215(19990301)80:5<699::aid-ijc12>3.0.co;2-7
- van der Gulden, 1994, Br J Urol., 73, 382, 10.1111/j.1464-410X.1994.tb07601.x · doi:10.1111/j.1464-410x.1994.tb07601.x
- Kolonel, 1977, Lancet., 2, 566, 10.1016/S0140-6736(77)90714-0 · doi:10.1016/s0140-6736(77)90714-0
- Schuman, 1977, Cancer Treat Rep., 61, 181
- Niijima, 1980, Scand J Urol Nephrol., 55, 177
- Newell, 1998, Vet Radiol Ultrasound., 39, 332, 10.1111/j.1740-8261.1998.tb01616.x · doi:10.1111/j.1740-8261.1998.tb01616.x
- Talamini, 1993, Prev Med., 22, 400, 10.1006/pmed.1993.1033 · doi:10.1006/pmed.1993.1033
- Hayes, 1994, Cancer Causes Control., 5, 221, 10.1007/BF01830240 · doi:10.1007/bf01830240
- Lumey, 1997, Prostate., 33, 195, 10.1002/(SICI)1097-0045(19971101)33:3<195::AID-PROS8>3.0.CO;2-I · doi:10.1002/(sici)1097-0045(19971101)33:3<195::aid-pros8>3.0.co;2-i
- Giles, 2001, Ann Oncol., 12, 761, 10.1023/A:1011131105617 · doi:10.1023/a:1011131105617
- Plaskon, 2003, Cancer Epidemiol Biomarkers Prev., 12, 604
- Lotufo, 2000, Int J Cancer., 87, 141, 10.1002/1097-0215(20000701)87:1<141::AID-IJC21>3.0.CO;2-A · doi:10.1002/1097-0215(20000701)87:1<141::aid-ijc21>3.0.co;2-a
- Whittemore, 1985, J Natl Cancer Inst., 74, 43
- Carstensen, 1987, J Epidemiol Commun Health., 41, 166, 10.1136/jech.41.2.166 · DOI
- Giovannucci, 1999, Cancer Epidemiol Biomarkers Prev., 8, 277
- Colditz, 1996, Cancer Causes Control., 7, 560, 10.1007/BF00051890 · doi:10.1007/bf00051890
- Yu, 1997, Cancer Detect Prev., 21, 497
- Verhoeven, 1996, Cancer Epidemiol Biomarkers Prev., 5, 733
- Schuurman, 1998, Cancer Epidemiol Biomarkers Prev., 7, 673
- Kolonel, 2000, Cancer Epidemiol Biomarkers Prev., 9, 795
- Lee, 2003, Cancer Epidemiol Biomarkers Prev., 12, 665
- Gann, 1999, Cancer Res., 59, 1225
- Clinton, 1996, Cancer Epidemiol Biomarkers Prev., 5, 823
- Imaida, 2001, Carcinogenesis., 22, 467, 10.1093/carcin/22.3.467 · doi:10.1093/carcin/22.3.467
- Watson, 1995, Environ Health Perspect., 103, 41
- Soto, 1995, Environ Health Perspect., 103, 113
200 of 902 shown
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
Tang, W.-Y., Morey, L. M., Cheung, Y. Y., Birch, L., Prins, G. S., & Ho, S.-M. (2012) · Endocrinology · doi:10.1210/en.2011-1308 · Cited by 164
Self-citationBarrington, W. E., Schenk, J. M., Etzioni, R., Arnold, K. B., Neuhouser, M. L., Thompson, I. M., Lucia, M. S., & Kristal, A. R. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0513 · Cited by 107
Metadata
- Authors
- Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., & Timms, B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004
- Volume
- 101
- Issue
- S10
- Pages
- 2371-2490
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2121518362
- Cited by
- 650
- References
- 914
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4261 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.